Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
6,650
-
Shares change
-
-276,641
-
Total reported value, excl. options
-
$4,000
-
Value change
-
-$143,302
-
Number of buys
-
1
-
Number of sells
-
-5
-
Price
-
$0.6349
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2016
8 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q2 2016.
IGC Pharma, Inc. - COM NEW (IGC) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,650 shares
.
Largest 8 shareholders include Creative Planning (3,150 shares), Gradient Investments LLC (2,000 shares), LADENBURG THALMANN FINANCIAL SERVICES INC (1,500 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares), TWO SIGMA SECURITIES, LLC (0 shares), CITADEL ADVISORS LLC (0 shares), UBS Group AG (0 shares), and KCG Holdings, Inc. (0 shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.